AUS
NZ
UK
CA
USA
IND
Highlights:
ASX rises strongly during midday trade amid easing trade tensions between the US and China
Neuren Pharmaceuticals jumps after Phase 3 trial confirmation for rare neurological condition
Grand Gulf Energy leads small caps as resource and energy shares rebound
The Australian sharemarket climbed during midday trade, driven by global sentiment shifting after a series of trade announcements from the United States. Local shares moved higher following a strong lead from Wall Street, where major indices closed in positive territory despite concerns over capital flows.
Investors responded to signals that the United States would exempt select consumer electronics from incoming reciprocal tariffs, a move welcomed by Chinese officials as progress in trade dialogue. However, upcoming changes to US semiconductor policy remain in focus, with short-term relief possibly giving way to new restrictions.
Resources and Energy Stocks Regain Momentum
Mining and energy companies on the ASX gained as commodity prices firmed. Iron ore producers rose as the commodity continued to climb, with names like BHP and Rio Tinto advancing alongside the broader sector.
Oil producers also recovered from recent losses, following reports of renewed diplomatic discussions between the US and Iran. These talks, held in Oman, marked the first high-level engagement since diplomatic efforts stalled in previous years. Developments on this front contributed to a stronger performance from local energy names.
Gold Sector Activity Fueled by M&A Developments
Gold stocks continued to attract attention amid elevated global demand and corporate developments. De Grey Mining saw gains after shareholder Gold Road Resources expressed support for Northern Star Resources’ acquisition proposal. The proposed deal has brought renewed focus to consolidation trends within the Australian gold mining sector.
Mergers and acquisitions remain a driving force behind movements in gold-related equities, especially with prices for the metal staying elevated on international markets.
Neuren Pharmaceuticals Drives Healthcare Gains
Biotechnology firm Neuren Pharmaceuticals was a standout performer in the healthcare sector. The company reported confirmation of its primary endpoints for an upcoming Phase 3 clinical trial of NNZ-2591, designed to assess its impact on communication challenges in children with Phelan-McDermid Syndrome.
Following interaction with US regulatory authorities, the trial is scheduled to commence mid-year. Previous studies on NNZ-2591 have shown measurable improvement in communication among children diagnosed with the condition.
The company stated that funding for the trial has been secured. If completed, this would represent a significant step forward in research targeting a disorder for which no approved therapies currently exist.
Small Cap Spotlight: Grand Gulf Energy
Among small cap companies, Grand Gulf Energy delivered a notable intraday performance. The energy explorer posted sharp gains, leading its segment during the trading session.
Broader interest in the small cap energy sector has been buoyed by renewed discussions around global oil supply and demand, with junior exploration firms drawing attention on the back of macro developments.
This activity came amid a broader rally across the ASX, where confidence lifted following geopolitical and economic signals from global markets.
